Futura Medical (LON:FUM) Releases Quarterly Earnings Results

Futura Medical (LON:FUM) announced its quarterly earnings data on Tuesday. The company reported GBX (0.20) EPS for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%.

Futura Medical Stock Down 1.8%

Shares of FUM traded down GBX 0.01 during mid-day trading on Tuesday, reaching GBX 0.37. The company’s stock had a trading volume of 22,394,688 shares, compared to its average volume of 9,153,882. Futura Medical has a 1 year low of GBX 0.24 and a 1 year high of GBX 10.45. The company has a market cap of £2.17 million, a price-to-earnings ratio of -0.13 and a beta of 0.02. The business has a fifty day moving average of GBX 0.43 and a 200 day moving average of GBX 0.80.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.